In a recent announcement, Curiox Biosystems Co. Ltd (Curiox) and Beckman Coulter Life Sciences have formed a strategic partnership to provide researchers with a seamless solution for hands-free washed sample preparation for flow cytometry. This collaboration integrates Curiox’s C-FREE technology with Beckman Coulter’s DURAClone dry pre-formulated antibody panels and customized DURA Innovations dry reagent antibody cocktails, offering a comprehensive workflow solution for researchers around the globe.
Improving standardization, automation, and reproducibility in flow cytometry laboratories, this partnership aims to empower the scientific community by providing efficient and reliable tools for advancing research and healthcare. Namyong Kim, CEO of Curiox Biosystems, emphasizes the importance of combining strengths to drive significant advancements in the field of life sciences. Pietro Lopriore, Vice President and General Manager of Flow Cytometry at Beckman Coulter Life Sciences, highlights the importance of speed and accuracy in delivering results to researchers, ultimately leading to pioneering discoveries.
This collaboration is set to accelerate the research and development of next-generation therapies, vaccines, and biomanufacturing processes, ultimately making a positive impact on lives worldwide.
Curiox Biosystems Co. Ltd is a rapidly growing biotechnology company specializing in advanced sample preparation solutions that enhance next-generation therapies. By leveraging expertise in surface chemistry and instrumentation, Curiox addresses challenges in life science research through miniaturization and automation, boosting productivity and speeding up therapeutic development. Their C-FREE technology enables significant scientific breakthroughs, positioning Curiox as a key player in transforming life sciences research and diagnostics on a global scale.
Beckman Coulter Life Sciences is a leader in laboratory automation and innovation, offering solutions for Centrifugation, Flow Cytometry, Genomics, Particle Analysis, and Liquid Handling workflows. With a legacy dating back to 1935, Beckman Coulter’s technologies aim to accelerate answers to important scientific questions, improve patient care, and enable pioneering discoveries. Part of the Danaher Corporation family, Beckman Coulter Life Sciences is headquartered in Indianapolis, Indiana, with operational hubs worldwide and employs approximately 2,800 associates.
For more information on the strategic partnership between Curiox and Beckman Coulter Life Sciences, visit both companies’ websites. Stay updated on the latest developments by following them on LinkedIn. If you have any specific inquiries, please reach out to the designated contact persons from each company.
Overall, this collaboration marks an exciting step forward in redefining the standards of quality and efficiency in flow cytometry research, showcasing how complementary technologies can unite to advance scientific research and positively impact lives globally.
Source link
